Top Tweets for #STARLATAMAB

9 months ago

Not incremental. Practice-changing. DeLLphi-304: Tarlatamab vs chemotherapy in relapsed SCLC . 13.6 vs 8.3 months OS | HR 0.60 When hazards weren’t proportional, RMST told the real PFS story. One of the most impactful survival trials of 2025. #SCLC #STARLATAMAB #DeLLphi304

ChandrakanthMv's tweet photo. Not incremental. Practice-changing.
DeLLphi-304: Tarlatamab vs chemotherapy in relapsed SCLC .
13.6 vs 8.3 months OS | HR 0.60
When hazards weren’t proportional, RMST told the real PFS story.
One of the most impactful survival trials of 2025.

#SCLC #STARLATAMAB #DeLLphi304

OncLive.com

@OncLive

over 1 year ago

Tarlatamab could become a new standard in 2L #SCLC — showing improved survival, better QoL, and manageable safety. A major drug for #SCLC @charlesrudin As @BalazsHalmosMD said - #starlatamab is born! @Jani_Chinmay

Top Tweets for #STARLATAMAB

Last Seen Hashtags on Sotwe

Trends for you

Most Popular Users